Skip to main content

Dermatologic & Topical Urethral Pharmacotherapy

Topical and intralesional therapies include treatments for genital dermatoses (lichen sclerosus, lichen planus, plasma-cell balanitis), anogenital warts, and Hunner lesions; adjunctive treatment of established urethral strictures; and investigational regenerative urologic applications. The category includes high-potency topical corticosteroids (used for LS), topical calcineurin inhibitors (steroid-sparing), selected intralesional treatments and investigational stricture adjuncts, the Optilume paclitaxel-coated balloon to treat obstructive symptoms associated with anterior urethral strictures up to 3 cm long in adult men, and platelet-rich plasma as an investigational biologic.

For oral systemic Peyronie's pharmacotherapy see Peyronie's Disease Agents in Sexual Medicine & Andrology. For lichen sclerosus clinical management see the linked condition page.

  • High-Potency Topical CorticosteroidsClobetasol and other potent topical steroids for lichen sclerosus: induction, maintenance and safe use on genital skin.
  • Topical Calcineurin InhibitorsTacrolimus and pimecrolimus as steroid-sparing treatment for genital dermatoses, and what their boxed warning means.
  • Intralesional CorticosteroidsTriamcinolone for Hunner lesions and selected specialist applications. Off-label formulation limits; uncertain stricture/BNC benefit; systemic absorption and pediatric safety.
  • Antimitotics & AntifibroticsMitomycin C, paclitaxel and experimental antifibrotic approaches. Clinical-trial boundaries for stricture injections, necrosis/fistula cautions and the DCB evidence comparison.
  • Drug-Coated Balloon Therapy (Optilume)Optilume (paclitaxel): US anterior-stricture label versus recurrent bulbar guideline selection, ROBUST trials, device instructions and required contraception counseling.
  • Platelet-Rich Plasma (PRP)Investigational PRP in bladder pain, ED, stricture, incontinence and genital disease. Conflicting controlled trials, uncontrolled-study limitations and preparation safety.
  • HPV / Condyloma Topical AgentsTopical treatments for anogenital warts, including patient-applied and clinician-applied options and special situations.